» Articles » PMID: 29031029

Glutathione Peroxidase Activity, Plasma Total Antioxidant Capacity, and Urinary F2- Isoprostanes As Markers of Oxidative Stress in Anemic Dogs

Overview
Date 2017 Oct 15
PMID 29031029
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oxidative stress plays a role in the pathophysiology of several diseases and has been documented as a contributor to disease in both the human and veterinary literature. One at-risk cell is the erythrocyte, however, the role of oxidative stress in anemia in dogs has not been widely investigated.

Hypothesis/objective: Anemic dogs will have an alteration in the activity of glutathione peroxidase (GPx), a decrease in of total antioxidant capacity (TAC), and an increased concentration of urinary 15-F -isoprostanes (F -IsoP) when compared to healthy dogs.

Animals: 40 client-owned dogs with anemia (PCV <30%) age-matched to 40 client-owned healthy control dogs.

Methods: Prospective, cross-sectional study. Whole blood GPx activity, plasma TAC, and urinary F -isoprostane concentrations were evaluated in each dog and compared between groups.

Results: Anemic dogs had significantly lower GPx activity (43.1 × 10 +/- 1.6 × 10 U/L) than did dogs in the control group (75.8 × 10 +/- 2.0 × 10 U/L; P < 0.0001). The GPx activity in dogs with hemolysis (10 +/- 0.8 × 10 U/L) was not significantly different (P = 0.57) than in dogs with nonhemolytic anemia (43.5 × 10 +/- 1.1 × 10 U/L). The TAC concentrations (P = 0.15) and urinary F -isoprostanes (P = 0.73) did not significantly differ between groups.

Conclusions And Clinical Importance: Glutathione peroxidase activity was significantly decreased in anemic dogs indicating oxidative stress. Additional studies are warranted to determine if antioxidant supplementation would improve survival and overall outcome as part of a therapeutic regimen for anemic dogs.

Citing Articles

Case report: Suspected propofol associated Heinz body anemia in five mechanically ventilated dogs: a historical case series.

Ireland E, Sharp C, Leister E, Boyd S Front Vet Sci. 2025; 12:1500464.

PMID: 39963275 PMC: 11831891. DOI: 10.3389/fvets.2025.1500464.


Oxidative Stress in Canine Diseases: A Comprehensive Review.

Blanca P, Maria Luisa F, Guadalupe M, Fatima C Antioxidants (Basel). 2024; 13(11).

PMID: 39594538 PMC: 11591346. DOI: 10.3390/antiox13111396.


Hemolysis, icterus and lipemia interfere with the determination of two oxidative stress biomarkers in canine serum.

Perez-Montero B, Fermin-Rodriguez M, Miro G, Juan L, Cruz-Lopez F BMC Vet Res. 2023; 19(1):172.

PMID: 37741986 PMC: 10517482. DOI: 10.1186/s12917-023-03740-y.


Antioxidant Nanozymes: Mechanisms, Activity Manipulation, and Applications.

Thao N, Do H, Nhat Nam N, Tran N, Dan T, Trinh K Micromachines (Basel). 2023; 14(5).

PMID: 37241640 PMC: 10220853. DOI: 10.3390/mi14051017.


Potential mechanism for hyperhomocysteinemia in Greyhound dogs.

Johnson K, Tiedeman T, Peterson H, Steiner J, Trepanier L J Vet Intern Med. 2023; 37(3):960-967.

PMID: 37092349 PMC: 10229318. DOI: 10.1111/jvim.16700.


References
1.
Freeman L, Rush J, Milbury P, Blumberg J . Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure. J Vet Intern Med. 2005; 19(4):537-41. DOI: 10.1892/0891-6640(2005)19[537:asaboo]2.0.co;2. View

2.
Morrow J, Roberts L . The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res. 1997; 36(1):1-21. DOI: 10.1016/s0163-7827(97)00001-5. View

3.
Viviano K, VanderWielen B . Effect of N-acetylcysteine supplementation on intracellular glutathione, urine isoprostanes, clinical score, and survival in hospitalized ill dogs. J Vet Intern Med. 2013; 27(2):250-8. DOI: 10.1111/jvim.12048. View

4.
Viviano K, Lavergne S, Goodman L, VanderWielen B, Grundahl L, Padilla M . Glutathione, cysteine, and ascorbate concentrations in clinically ill dogs and cats. J Vet Intern Med. 2009; 23(2):250-7. DOI: 10.1111/j.1939-1676.2008.0238.x. View

5.
Koren E, Kohen R, Ginsburg I . Polyphenols enhance total oxidant-scavenging capacities of human blood by binding to red blood cells. Exp Biol Med (Maywood). 2010; 235(6):689-99. DOI: 10.1258/ebm.2010.009370. View